Dr Mark AshtonÂ
Molecular Biosciences
vaxxas
Australia
Biography
Dr Ashton has worked within the biotech and pharmaceutical industry for the past 17 years. He joined UniQuest in 2010 and is currently the Manager of Innovation and Commercial Development for the Institute of Molecular Biosciences. Before joining UniQuest he was the Executive Vice President, Business Development at Evotec AG, a European based Biotech / CRO where he led a team responsible for the global commercial and marketing activities with the world’s leading pharmaceutical and biotechnology companies. Prior to leading the business development group Mark was President, Discovery Services, responsible for the Drug Discovery division of Evotec: a division of approximately 250 chemists and biologists involved in projects ranging from high throughput screening through parallel synthesis and medicinal chemistry to pre-clinical development. He has both operational and commercial experience of a wide range of life science projects and is the author and co-author on a number of reviewed scientific publications and patents.
Research Interest
Molecular Biosciences
